(S)-2-(2,2-Dimethyl-2H-chromen-6-yl)-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)chroman-4-one

Catalog No. :
ACKKWX079
CAS No. :
171828-81-2
Molecular Formula :
C25H26O5
Molecular Weight :
406.48

IUPAC Name:(S)-2-(2,2-dimethyl-2H-chromen-6-yl)-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)chroman-4-one

(S)-2-(2,2-Dimethyl-2H-chromen-6-yl)-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)chroman-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(2,2-Dimethyl-2H-chromen-6-yl)-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)chroman-4-one
IUPAC Name(S)-2-(2,2-dimethyl-2H-chromen-6-yl)-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)chroman-4-one
Molecular FormulaC25H26O5
Molecular Weight406.48
SMILESO=C1C[C@@H](C2=CC=C3C(C=CC(C)(C)O3)=C2)OC4=C(C/C=C(C)\C)C(O)=CC(O)=C14
InChI KeyQEHKYCUZABAYBC-QFIPXVFZSA-N
SynonymEuchrenone A10;(2S)-5,7-Dihydroxy-2',2'-dimethyl-8-(3-methyl-2-buten-1-yl)-[2,6'-bi-2H-1-benzopyran]-4(3H)-one;[2,6'-Bi-2H-1-benzopyran]-4(3H)-one, 5,7-dihydroxy-2',2'-dimethyl-8-(3-methyl-2-buten-1-yl)-, (2S)-;CAS:171828-81-2
CAS No.171828-81-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKKWX079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKKWX079 route product structure diagram
    ACKKWX079171828-81-2
Inquiry

2. ACKKWX079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKKWX079 route product structure diagram
    ACKKWX079171828-81-2
Inquiry

Comments (0)